Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma: GHSG HD21, a randomized study.

Peter Borchmann; Alden A. Moccia; Richard Greil; Gundolf Schneider; Mark Hertzberg; Valdete Schaub; Andreas Huettmann; Felix Keil; Judith Dierlamm; Mathias Haenel; Julia Meissner; Stephan Mathas; Josee M. Zijlstra; Alexander Fossa; Justin Ferdinandus; Michael Fuchs; Wolfram Klapper; Hans-Theodor Eich; Carsten Kobe; Volker Diehl

doi:10.1200/JCO.2024.42.17_suppl.LBA7000

Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma: GHSG HD21, a randomized study.

Peter Borchmann, Alden A. Moccia, Richard Greil, Gundolf Schneider, Mark Hertzberg, Valdete Schaub, Andreas Huettmann, Felix Keil, Judith Dierlamm, Mathias Haenel, Julia Meissner, Stephan Mathas, Josee M. Zijlstra, Alexander Fossa, Justin Ferdinandus, Michael Fuchs, Wolfram Klapper, Hans-Theodor Eich, Carsten Kobe, Volker Diehl

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

4 Citations (Web of Science)

Original language	English
Pages (from-to)	LBA7000-LBA7000
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	42
Issue number	17_SUPPL
DOIs	https://doi.org/10.1200/JCO.2024.42.17_suppl.LBA7000
Publication status	Published - 10 Jun 2024

Access to Document

10.1200/JCO.2024.42.17_suppl.LBA7000

Cite this

Borchmann, P., Moccia, A. A., Greil, R., Schneider, G., Hertzberg, M., Schaub, V., Huettmann, A., Keil, F., Dierlamm, J., Haenel, M., Meissner, J., Mathas, S., Zijlstra, J. M., Fossa, A., Ferdinandus, J., Fuchs, M., Klapper, W., Eich, H.-T., Kobe, C., & Diehl, V. (2024). Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma: GHSG HD21, a randomized study. Journal of Clinical Oncology, 42(17_SUPPL), LBA7000-LBA7000. https://doi.org/10.1200/JCO.2024.42.17_suppl.LBA7000

@article{89fc51c8775f483f99922e856398d5b9,

title = "Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma: GHSG HD21, a randomized study.",

author = "Peter Borchmann and Moccia, {Alden A.} and Richard Greil and Gundolf Schneider and Mark Hertzberg and Valdete Schaub and Andreas Huettmann and Felix Keil and Judith Dierlamm and Mathias Haenel and Julia Meissner and Stephan Mathas and Zijlstra, {Josee M.} and Alexander Fossa and Justin Ferdinandus and Michael Fuchs and Wolfram Klapper and Hans-Theodor Eich and Carsten Kobe and Volker Diehl",

year = "2024",

month = jun,

day = "10",

doi = "10.1200/JCO.2024.42.17_suppl.LBA7000",

language = "English",

volume = "42",

pages = "LBA7000--LBA7000",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

number = "17_SUPPL",

}

Borchmann, P, Moccia, AA, Greil, R, Schneider, G, Hertzberg, M, Schaub, V, Huettmann, A, Keil, F, Dierlamm, J, Haenel, M, Meissner, J, Mathas, S, Zijlstra, JM, Fossa, A, Ferdinandus, J, Fuchs, M, Klapper, W, Eich, H-T, Kobe, C & Diehl, V 2024, 'Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma: GHSG HD21, a randomized study.', Journal of Clinical Oncology, vol. 42, no. 17_SUPPL, pp. LBA7000-LBA7000. https://doi.org/10.1200/JCO.2024.42.17_suppl.LBA7000

TY - JOUR

T1 - Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma

T2 - GHSG HD21, a randomized study.

AU - Borchmann, Peter

AU - Moccia, Alden A.

AU - Greil, Richard

AU - Schneider, Gundolf

AU - Hertzberg, Mark

AU - Schaub, Valdete

AU - Huettmann, Andreas

AU - Keil, Felix

AU - Dierlamm, Judith

AU - Haenel, Mathias

AU - Meissner, Julia

AU - Mathas, Stephan

AU - Zijlstra, Josee M.

AU - Fossa, Alexander

AU - Ferdinandus, Justin

AU - Fuchs, Michael

AU - Klapper, Wolfram

AU - Eich, Hans-Theodor

AU - Kobe, Carsten

AU - Diehl, Volker

PY - 2024/6/10

Y1 - 2024/6/10

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pmu_pure&SrcAuth=WosAPI&KeyUT=WOS:001244441000044&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1200/JCO.2024.42.17_suppl.LBA7000

DO - 10.1200/JCO.2024.42.17_suppl.LBA7000

M3 - Abstract (Journal)

SN - 0732-183X

VL - 42

SP - LBA7000-LBA7000

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 17_SUPPL

ER -

Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma: GHSG HD21, a randomized study.

Access to Document

Other files and links

Cite this